Zhong B, Du J, Liu F, Sun S
MedComm (2020). 2025; 6(3):e70128.
PMID: 40066231
PMC: 11892025.
DOI: 10.1002/mco2.70128.
Najm M, Martignetti L, Cornet M, Kelly-Aubert M, Sermet I, Calzone L
BMC Genomics. 2024; 25(1):892.
PMID: 39342081
PMC: 11438383.
DOI: 10.1186/s12864-024-10752-x.
Wen Y, Lin M, Liu J, Tang J, Qi X
Biochem Biophys Rep. 2024; 37:101604.
PMID: 38188360
PMC: 10767314.
DOI: 10.1016/j.bbrep.2023.101604.
Schneider-Futschik E, Lobert V, Wilson J
Front Physiol. 2022; 12:830285.
PMID: 35140634
PMC: 8819176.
DOI: 10.3389/fphys.2021.830285.
Cmielewski P, Delhove J, Donnelley M, Parsons D
Front Pharmacol. 2021; 12:714452.
PMID: 34385926
PMC: 8353152.
DOI: 10.3389/fphar.2021.714452.
Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation.
Della Sala A, Prono G, Hirsch E, Ghigo A
Front Physiol. 2021; 12:690247.
PMID: 34211404
PMC: 8240754.
DOI: 10.3389/fphys.2021.690247.
Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings.
Bratcher P, Yadav S, Shaughnessy C, Thornell I, Zeitlin P
Physiol Rep. 2020; 8(19):e14603.
PMID: 33038073
PMC: 7547589.
DOI: 10.14814/phy2.14603.
Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
Guggino W, Cebotaru L
Hum Gene Ther. 2020; 31(9-10):538-541.
PMID: 32283956
PMC: 7232693.
DOI: 10.1089/hum.2020.046.
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?.
Keeler A, Flotte T
Annu Rev Virol. 2019; 6(1):601-621.
PMID: 31283441
PMC: 7123914.
DOI: 10.1146/annurev-virology-092818-015530.
Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure.
Cabrini G
Mol Diagn Ther. 2018; 23(2):263-279.
PMID: 30478715
DOI: 10.1007/s40291-018-0372-6.
Molecular basis of cystic fibrosis: from bench to bedside.
Dechecchi M, Tamanini A, Cabrini G
Ann Transl Med. 2018; 6(17):334.
PMID: 30306073
PMC: 6174194.
DOI: 10.21037/atm.2018.06.48.
Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.
Guggino W, Cebotaru L
Expert Opin Biol Ther. 2017; 17(10):1265-1273.
PMID: 28657358
PMC: 5858933.
DOI: 10.1080/14712598.2017.1347630.
Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Ganglia of Human Gastrointestinal Tract.
Xue R, Gu H, Qiu Y, Guo Y, Korteweg C, Huang J
Sci Rep. 2016; 6():30926.
PMID: 27491544
PMC: 4974654.
DOI: 10.1038/srep30926.
Role of Interaction and Nucleoside Diphosphate Kinase B in Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Function by cAMP-Dependent Protein Kinase A.
Borthwick L, Kerbiriou M, Taylor C, Cozza G, Lascu I, Postel E
PLoS One. 2016; 11(3):e0149097.
PMID: 26950439
PMC: 4780765.
DOI: 10.1371/journal.pone.0149097.
Development of rAAV2-CFTR: History of the First rAAV Vector Product to be Used in Humans.
Loring H, Elmallah M, Flotte T
Hum Gene Ther Methods. 2016; 27(2):49-58.
PMID: 26895204
PMC: 4834522.
DOI: 10.1089/hgtb.2015.150.
Disruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.
Clauzure M, Valdivieso A, Massip Copiz M, Schulman G, Teiber M, Santa-Coloma T
PLoS One. 2014; 9(6):e99257.
PMID: 24901709
PMC: 4047112.
DOI: 10.1371/journal.pone.0099257.
Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.
Flotte T
Mol Ther. 2013; 21(11):1976-81.
PMID: 24201212
PMC: 3831048.
DOI: 10.1038/mt.2013.226.
Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing.
Montiel-Gonzalez M, Vallecillo-Viejo I, Yudowski G, Rosenthal J
Proc Natl Acad Sci U S A. 2013; 110(45):18285-90.
PMID: 24108353
PMC: 3831439.
DOI: 10.1073/pnas.1306243110.
A distal enhancer controls cytokine-dependent human cPLA2α gene expression.
Bickford J, Beachy D, Newsom K, Barilovits S, Herlihy J, Qiu X
J Lipid Res. 2013; 54(7):1915-26.
PMID: 23549331
PMC: 3679393.
DOI: 10.1194/jlr.M037382.
The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.
Valdivieso A, Clauzure M, Marin M, Taminelli G, Massip Copiz M, Sanchez F
PLoS One. 2012; 7(11):e48059.
PMID: 23185247
PMC: 3504030.
DOI: 10.1371/journal.pone.0048059.